Home/Filings/4/0001104659-25-003496
4//SEC Filing

Kalin Katherine Bach 4

Accession 0001104659-25-003496

CIK 0001390478other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 5:31 PM ET

Size

15.6 KB

Accession

0001104659-25-003496

Insider Transaction Report

Form 4
Period: 2025-01-10
Transactions
  • Award

    Common Stock

    2025-01-10+12,50021,000 total
  • Award

    Stock Option (Right to Buy)

    2025-01-10+18,50018,500 total
    Exercise: $0.95Exp: 2035-01-10Common Stock (18,500 underlying)
Footnotes (2)
  • [F1]The Reporting Person received an award of 12,500 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
  • [F2]The shares subject to the option will fully vest on the earlier of (x) January 10, 2026 (the first anniversary of the date of grant) or (y) the business day prior to the 2026 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.

Issuer

SELLAS Life Sciences Group, Inc.

CIK 0001390478

Entity typeother

Related Parties

1
  • filerCIK 0001832671

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 5:31 PM ET
Size
15.6 KB